Clinical Trial Update: An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 exploratory clinical study of dalpiciclib combined with aromatase inhibitor neoadjuvant therapy for stage II-III HR+/HER2- breast cancer; not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dalpiciclib (dalpiciclib)

Snippet

Sponsor: Jiangsu Famous Medical Technology Co., Ltd. | Conditions: Breast Cancer | Phase 4 | Status: NOT_YET_RECRUITING